Earnings Alert: Bruker Corporation (NASDAQ: BRKR)

On Friday, Bruker Corporation (NASDAQ: BRKR) stock price moved up at 0.73%. Its day lowest price was $49.38 and its hit its day highest price at $49.96. The stock recent volume is 1329868 shares in comparison to its average trading volume of 516663 shares. Looking at the stock’s price level on the past 52-week graph, BRKR recorded a 52-week high of $52.23 and its 52-week low of $26.1.

Bruker Corporation (BRKR) recently reported financial results for its third quarter and for the nine months ended September 30, 2019.

Third Quarter 2019 Financial Results

Bruker’s revenues for the third quarter of 2019 were $521.1M, a raise of 11.7% contrast to the third quarter of 2018. In the third quarter of 2019, Bruker’s year-over-year organic revenue growth was 7.6%. Growth from acquisitions was 6.4%, while foreign currency translation had a negative effect of 2.3%.

Third quarter 2019 Bruker Scientific Instruments (BSI) section revenues of $471.8M increased 13.1% year-over-year, including organic growth of 8.6%. Third quarter 2019 Bruker Energy & Supercon Technologies (BEST) section revenues of $52.5M increased 3.1% year-over-year, including an organic revenue decline of 0.8%, net of inter-company eliminations.

Third quarter 2019 GAAP operating income was $87.8M, contrast to $69.1M in the third quarter of 2018, representing GAAP operating margins of 16.8% and 14.8%, respectively. Non-GAAP operating income was $95.5M, contrast to $83.3M in the third quarter of 2018. Bruker’s third quarter 2019 non-GAAP operating margin of 18.3% increased 40 basis points from 17.9% in the third quarter of 2018.

Third quarter 2019 GAAP diluted earnings per share (EPS) were $0.39, contrast to $0.28 in the third quarter of 2018. Non-GAAP EPS were $0.43, a 16.2% increase contrast to $0.37 in the third quarter of 2018.

First Nine Months of 2019 Financial Results

For the first nine months of 2019, Bruker’s revenues were $1,472.7M, a raise of 9.7% from $1,342.0M in the first nine months of 2018. In the first nine months of 2019, Bruker’s organic revenue growth was 6.0% year-over-year. Growth from acquisitions was 7.0%, while foreign currency translation had a negative effect of 3.3%.

In the first nine months of 2019, BSI section revenues of $1,331.0M increased 10.3% year-over-year, including organic growth of 5.8%. First nine months 2019 BEST section revenues of $152.2M increased 9.3% year-over-year, including organic growth of 7.0%, net of inter-company eliminations.

In the first nine months of 2019, GAAP operating income was $183.2M, contrast to $156.0M in the first nine months of 2018, representing GAAP operating margins of 12.4% and 11.6%, respectively. Non-GAAP operating income was $231.5M, contrast to $195.1M in the first nine months of 2018. Bruker’s non-GAAP operating margin in the first nine months of 2019 was 15.7%, a raise of 120 basis points, contrast to 14.5% in the first nine months of 2018.

The one-month performance of stock was 14.23%. BRKR’s shares are at 20.29% for the quarter and driving a 56.79% return over the course of the past year and is now at 67.48% since this point in 2018.  Right now, the stock beta is 1.41. The average volatility for the week and month was at 2.02% and 2.59% respectively.

 

Leave a Reply

Your email address will not be published. Required fields are marked *